Caplin Point Laboratories share news and announcements
NSE: CAPLIPOINTBSE: 524742Pharmaceuticals & BiotechnologySmall Cap
Last close ₹2,222.00down ₹27.10 (1.20%)BSE ₹2,222.15
Share price at the NSE close on 23 Oct 2026. Previous close ₹2,249.10.
52-week range of traded prices to 23 Oct 2026
₹1,500.30Low, 30 Mar 2026₹2,990.00High, 24 Sep 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹16,890 Cr453rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 12 Aug 2026
- 25.4
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 14 May 2026
- 4.7
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.36%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 12 Aug 2026
- 20.7%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 12 Aug 2026
- 19.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 14 May 2026
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 76,90447.0% delivered
Caplin Point Laboratories routine notices
196 filed, newest first. Page 4 of 4.
Jan 2022
Dec 2021
9 Dec · Routine
7 Dec · Routine
Nov 2021
20 Nov · Routine
Oct 2021
21 Oct · Routine
Sep 2021
29 Sep · Routine
23 Sep · Routine
22 Sep · Routine
6 Sep · Routine
2 Sep · Routine
Aug 2021
31 Aug · Routine
14 Aug · Routine
Jul 2021
16 Jul · Routine
14 Jul · Routine
8 Jul · Routine
Jun 2021
26 Jun · Routine
Apr 2021
13 Apr · Routine
Mar 2021
18 Mar · Routine
2 Mar · Routine
Feb 2021
17 Feb · Routine
Jan 2021
12 Jan · Routine
Dec 2020
28 Dec · Routine
9 Dec · Routine
Nov 2020
5 Nov · Routine
Oct 2020
1 Oct · Routine
Sep 2020
Jun 2020
Mar 2020
Dec 2019
Sep 2019
Jun 2019
Apr 2019
Apr 2017
Oct 2016
May 2016
Jan 2016
Oct 2015
Aug 2015
May 2015
Jan 2015
23 Jan · Routine
Trading window will be closed from January 31, 2015 to February 4, 2015 (both days inclusive) in connection with the approval of the Un-Audited financial results and shall reopen after the expiry of 24 hours from the time of publication of Un-Audited financial results